nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—RYR2—dilated cardiomyopathy	0.814	1	CbGaD
Hydralazine—RYR2—sinoatrial node—dilated cardiomyopathy	0.0519	0.631	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCD—dilated cardiomyopathy	0.0108	0.19	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—DSG2—dilated cardiomyopathy	0.00568	0.1	CbGpPWpGaD
Hydralazine—RYR2—cardiac ventricle—dilated cardiomyopathy	0.00461	0.056	CbGeAlD
Hydralazine—RYR2—myocardium—dilated cardiomyopathy	0.00434	0.0527	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—dilated cardiomyopathy	0.00431	0.0758	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.004	0.0705	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.0034	0.0599	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.00326	0.0574	CbGpPWpGaD
Hydralazine—RYR2—heart—dilated cardiomyopathy	0.00303	0.0368	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00291	0.0512	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.00285	0.0502	CbGpPWpGaD
Hydralazine—AOC3—cardiac ventricle—dilated cardiomyopathy	0.00278	0.0337	CbGeAlD
Hydralazine—AOC3—myocardium—dilated cardiomyopathy	0.00261	0.0317	CbGeAlD
Hydralazine—RYR2—cardiac atrium—dilated cardiomyopathy	0.00259	0.0315	CbGeAlD
Hydralazine—P4HA1—cardiac ventricle—dilated cardiomyopathy	0.00222	0.027	CbGeAlD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ACTC1—dilated cardiomyopathy	0.00222	0.039	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00209	0.0368	CbGpPWpGaD
Hydralazine—P4HA1—myocardium—dilated cardiomyopathy	0.00209	0.0254	CbGeAlD
Hydralazine—RYR2—Ion channel transport—PLN—dilated cardiomyopathy	0.00196	0.0344	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00195	0.0344	CbGpPWpGaD
Hydralazine—AOC3—heart—dilated cardiomyopathy	0.00182	0.0221	CbGeAlD
Hydralazine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00176	0.0374	CcSEcCtD
Hydralazine—AOC3—cardiac atrium—dilated cardiomyopathy	0.00156	0.0189	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.00147	0.0259	CbGpPWpGaD
Hydralazine—P4HA1—heart—dilated cardiomyopathy	0.00146	0.0177	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.00139	0.0245	CbGpPWpGaD
Hydralazine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00135	0.0287	CcSEcCtD
Hydralazine—P4HA1—cardiac atrium—dilated cardiomyopathy	0.00125	0.0151	CbGeAlD
Hydralazine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00113	0.0239	CcSEcCtD
Hydralazine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00107	0.0227	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00102	0.0179	CbGpPWpGaD
Hydralazine—Vasculitis—Furosemide—dilated cardiomyopathy	0.00096	0.0203	CcSEcCtD
Hydralazine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000899	0.019	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000839	0.0148	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000824	0.0145	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GJA1—dilated cardiomyopathy	0.000813	0.0143	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000809	0.0142	CbGpPWpGaD
Hydralazine—Proteinuria—Lisinopril—dilated cardiomyopathy	0.0008	0.017	CcSEcCtD
Hydralazine—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000789	0.0167	CcSEcCtD
Hydralazine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00076	0.0161	CcSEcCtD
Hydralazine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000753	0.016	CcSEcCtD
Hydralazine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000748	0.0158	CcSEcCtD
Hydralazine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000724	0.0153	CcSEcCtD
Hydralazine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00072	0.0153	CcSEcCtD
Hydralazine—Purpura—Furosemide—dilated cardiomyopathy	0.000706	0.015	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000701	0.0124	CbGpPWpGaD
Hydralazine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000699	0.0148	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000681	0.012	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000681	0.012	CbGpPWpGaD
Hydralazine—Malaise—Spironolactone—dilated cardiomyopathy	0.000679	0.0144	CcSEcCtD
Hydralazine—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000674	0.0143	CcSEcCtD
Hydralazine—Urinary retention—Furosemide—dilated cardiomyopathy	0.000647	0.0137	CcSEcCtD
Hydralazine—Discomfort—Spironolactone—dilated cardiomyopathy	0.000633	0.0134	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000633	0.0111	CbGpPWpGaD
Hydralazine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000612	0.013	CcSEcCtD
Hydralazine—RYR2—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.000608	0.0107	CbGpPWpGaD
Hydralazine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000602	0.0127	CcSEcCtD
Hydralazine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000584	0.0124	CcSEcCtD
Hydralazine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000582	0.0123	CcSEcCtD
Hydralazine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000565	0.012	CcSEcCtD
Hydralazine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00056	0.0119	CcSEcCtD
Hydralazine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000553	0.0117	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00053	0.0112	CcSEcCtD
Hydralazine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000506	0.0107	CcSEcCtD
Hydralazine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000489	0.0104	CcSEcCtD
Hydralazine—Urticaria—Spironolactone—dilated cardiomyopathy	0.000488	0.0103	CcSEcCtD
Hydralazine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000486	0.0103	CcSEcCtD
Hydralazine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00046	0.00974	CcSEcCtD
Hydralazine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000453	0.00959	CcSEcCtD
Hydralazine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000437	0.00925	CcSEcCtD
Hydralazine—Pruritus—Spironolactone—dilated cardiomyopathy	0.000435	0.00921	CcSEcCtD
Hydralazine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00043	0.0091	CcSEcCtD
Hydralazine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00042	0.00891	CcSEcCtD
Hydralazine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000419	0.00887	CcSEcCtD
Hydralazine—Dysuria—Lisinopril—dilated cardiomyopathy	0.000412	0.00874	CcSEcCtD
Hydralazine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000412	0.00874	CcSEcCtD
Hydralazine—Dizziness—Spironolactone—dilated cardiomyopathy	0.000406	0.00861	CcSEcCtD
Hydralazine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000399	0.00845	CcSEcCtD
Hydralazine—RYR2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000397	0.00698	CbGpPWpGaD
Hydralazine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000394	0.00834	CcSEcCtD
Hydralazine—Depression—Lisinopril—dilated cardiomyopathy	0.000392	0.00831	CcSEcCtD
Hydralazine—Vomiting—Spironolactone—dilated cardiomyopathy	0.000391	0.00828	CcSEcCtD
Hydralazine—Rash—Spironolactone—dilated cardiomyopathy	0.000387	0.00821	CcSEcCtD
Hydralazine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000387	0.0082	CcSEcCtD
Hydralazine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000385	0.00817	CcSEcCtD
Hydralazine—Headache—Spironolactone—dilated cardiomyopathy	0.000385	0.00816	CcSEcCtD
Hydralazine—Jaundice—Lisinopril—dilated cardiomyopathy	0.000383	0.00812	CcSEcCtD
Hydralazine—Anaemia—Furosemide—dilated cardiomyopathy	0.000379	0.00802	CcSEcCtD
Hydralazine—Agitation—Furosemide—dilated cardiomyopathy	0.000376	0.00798	CcSEcCtD
Hydralazine—Haematuria—Lisinopril—dilated cardiomyopathy	0.000375	0.00794	CcSEcCtD
Hydralazine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000367	0.00778	CcSEcCtD
Hydralazine—Leukopenia—Furosemide—dilated cardiomyopathy	0.000367	0.00777	CcSEcCtD
Hydralazine—Nausea—Spironolactone—dilated cardiomyopathy	0.000365	0.00773	CcSEcCtD
Hydralazine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000353	0.00748	CcSEcCtD
Hydralazine—Hallucination—Lisinopril—dilated cardiomyopathy	0.000351	0.00744	CcSEcCtD
Hydralazine—Flushing—Lisinopril—dilated cardiomyopathy	0.000328	0.00694	CcSEcCtD
Hydralazine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000327	0.00693	CcSEcCtD
Hydralazine—Anorexia—Furosemide—dilated cardiomyopathy	0.000319	0.00675	CcSEcCtD
Hydralazine—Chills—Lisinopril—dilated cardiomyopathy	0.000317	0.00671	CcSEcCtD
Hydralazine—Hypotension—Furosemide—dilated cardiomyopathy	0.000312	0.00662	CcSEcCtD
Hydralazine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.0003	0.00636	CcSEcCtD
Hydralazine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000295	0.00626	CcSEcCtD
Hydralazine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000291	0.00616	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000289	0.00611	CcSEcCtD
Hydralazine—Tremor—Lisinopril—dilated cardiomyopathy	0.000288	0.0061	CcSEcCtD
Hydralazine—Constipation—Furosemide—dilated cardiomyopathy	0.000286	0.00606	CcSEcCtD
Hydralazine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000285	0.00604	CcSEcCtD
Hydralazine—Anaemia—Lisinopril—dilated cardiomyopathy	0.000284	0.00602	CcSEcCtD
Hydralazine—Malaise—Lisinopril—dilated cardiomyopathy	0.000277	0.00587	CcSEcCtD
Hydralazine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000275	0.00584	CcSEcCtD
Hydralazine—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000275	0.00583	CcSEcCtD
Hydralazine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000272	0.00575	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000267	0.0047	CbGpPWpGaD
Hydralazine—Urticaria—Furosemide—dilated cardiomyopathy	0.000266	0.00563	CcSEcCtD
Hydralazine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000264	0.0056	CcSEcCtD
Hydralazine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000262	0.00554	CcSEcCtD
Hydralazine—Myalgia—Lisinopril—dilated cardiomyopathy	0.000262	0.00554	CcSEcCtD
Hydralazine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000261	0.00552	CcSEcCtD
Hydralazine—Discomfort—Lisinopril—dilated cardiomyopathy	0.000258	0.00548	CcSEcCtD
Hydralazine—Oedema—Lisinopril—dilated cardiomyopathy	0.000251	0.00531	CcSEcCtD
Hydralazine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000246	0.00522	CcSEcCtD
Hydralazine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000246	0.0052	CcSEcCtD
Hydralazine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000245	0.00519	CcSEcCtD
Hydralazine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000239	0.00507	CcSEcCtD
Hydralazine—Pruritus—Furosemide—dilated cardiomyopathy	0.000236	0.00501	CcSEcCtD
Hydralazine—Hypotension—Lisinopril—dilated cardiomyopathy	0.000234	0.00497	CcSEcCtD
Hydralazine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000229	0.00485	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000229	0.00484	CcSEcCtD
Hydralazine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000225	0.00477	CcSEcCtD
Hydralazine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000224	0.00474	CcSEcCtD
Hydralazine—Dizziness—Furosemide—dilated cardiomyopathy	0.000221	0.00468	CcSEcCtD
Hydralazine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000221	0.00468	CcSEcCtD
Hydralazine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000218	0.00462	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000217	0.00459	CcSEcCtD
Hydralazine—Constipation—Lisinopril—dilated cardiomyopathy	0.000214	0.00454	CcSEcCtD
Hydralazine—Vomiting—Furosemide—dilated cardiomyopathy	0.000213	0.0045	CcSEcCtD
Hydralazine—Rash—Furosemide—dilated cardiomyopathy	0.000211	0.00447	CcSEcCtD
Hydralazine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000211	0.00446	CcSEcCtD
Hydralazine—Headache—Furosemide—dilated cardiomyopathy	0.000209	0.00444	CcSEcCtD
Hydralazine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000207	0.00438	CcSEcCtD
Hydralazine—Urticaria—Lisinopril—dilated cardiomyopathy	0.000199	0.00422	CcSEcCtD
Hydralazine—Nausea—Furosemide—dilated cardiomyopathy	0.000199	0.00421	CcSEcCtD
Hydralazine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000198	0.0042	CcSEcCtD
Hydralazine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000185	0.00392	CcSEcCtD
Hydralazine—Pruritus—Lisinopril—dilated cardiomyopathy	0.000177	0.00376	CcSEcCtD
Hydralazine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000172	0.00364	CcSEcCtD
Hydralazine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000166	0.00351	CcSEcCtD
Hydralazine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000159	0.00338	CcSEcCtD
Hydralazine—Rash—Lisinopril—dilated cardiomyopathy	0.000158	0.00335	CcSEcCtD
Hydralazine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000158	0.00335	CcSEcCtD
Hydralazine—Headache—Lisinopril—dilated cardiomyopathy	0.000157	0.00333	CcSEcCtD
Hydralazine—Nausea—Lisinopril—dilated cardiomyopathy	0.000149	0.00316	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000138	0.00243	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.35e-05	0.000414	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.21e-05	0.000389	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2e-05	0.000352	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.43e-06	9.56e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.29e-06	9.31e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.76e-06	8.38e-05	CbGpPWpGaD
